EPL clears BSE, NSE scrutiny for Indovida merger scheme
- EPL Limited received no adverse observation letters from BSE and NSE on October 19, 2026
- Clearance allows filing of merger scheme with Indovida India Private Limited before NCLT
- SEBI mandated detailed disclosures on share swap ratios, synergies, and pending legal actions
- Observation letters are valid for six months from the date of issue

*this image is generated using AI for illustrative purposes only.
EPL Limited has received 'no adverse observation' letters from both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) regarding its proposed merger with Indovida India Private Limited. This regulatory clearance enables the company to proceed with filing the scheme before the National Company Law Tribunal (NCLT).
The exchanges issued these letters on October 19, 2026, under Regulation 37 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The approval follows the Board's initial sanction of the Scheme of Amalgamation on March 29, 2026, and subsequent applications filed by EPL on April 22, 2026.
Regulatory Observations and Conditions
While granting no-objection status, both exchanges relayed specific comments from the Securities and Exchange Board of India (SEBI). These conditions mandate comprehensive disclosures to shareholders and strict compliance with listing norms. Key requirements include:
- Disclosure of all ongoing adjudication, recovery proceedings, and enforcement actions against the company, its promoters, and directors.
- Ensuring financials in the scheme and valuation reports are not older than six months.
- Detailed explanatory statements covering the need for merger, synergies, share-swap ratio basis, and pre- and post-merger shareholding patterns.
- Mandatory demat form for all equity shares issued under the scheme.
- Incorporation of all exchange observations in the petition filed before the NCLT.
Validity and Next Steps
The validity of the Observation Letters is six months from October 19, 2026. Within this period, EPL must submit the scheme to the NCLT. The exchanges reserved the right to withdraw their 'no adverse observation' if submitted information is found to be incomplete, incorrect, or misleading.
What the Numbers Show
The timeline indicates a seven-month progression from Board approval (March 29, 2026) to final exchange clearance (October 19, 2026). This duration reflects the time taken for SEBI's review process, which concluded with a letter dated October 16, 2026, just three days prior to the exchanges issuing their final letters. The tight turnaround between SEBI's comments and the exchanges' clearance suggests the documentation was largely compliant, requiring only standard procedural disclosures rather than substantive revisions to the scheme structure.
Historical Stock Returns for EPL
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.45% | -0.60% | -1.23% | +0.31% | +10.45% | 0.0% |
How will the specific synergies and share-swap ratio detailed in the upcoming NCLT petition impact EPL's post-merger valuation and market capitalization?
What are the potential risks to the merger timeline if the six-month validity period for the exchange letters expires before NCLT approval is secured?
How might the mandated disclosures regarding ongoing adjudication or enforcement actions against EPL's promoters influence investor sentiment and stock volatility upon the scheme's public release?


































